TABLE 3:

Differentiation of tumors as low versus high grade

ParameterHigh Grade (n = 16)Low Grade (n = 20)Benign (n = 13)Control (n = 15)F Score*P Value*
MeanSDMeanSDMeanSDMeanSD
NAA/Cho0.650.300.660.271.120.591.350.1416.520.000
NAA/Cr1.030.351.050.411.420.511.680.2810.051.000
NAA/Cho + Cr0.390.160.390.140.610.250.750.0118.406.000
Cho/Cr1.790.691.710.561.450.651.240.163.159.031
Lipid/Cr0.490.340.250.170.290.190.160.016.814.000§
Lactate/Cr0.360.210.220.220.010.140.000.0013.589.000|
Lactate/lipid0.930.840.780.740.180.430.000.008.292.000
Alanin/Cr0.000.000.000.000.210.280.000.0012.099.000#
ADCT87.1610.41115.3311.67107.698.0579.374.1054.741.000**
ADCPT148.5630.86167.1832.8294.2329.2379.374.1038.774.000††
  • Note.—ADCT indicates calculated ADC values from tumoral area; ADCPT, calculated ADC values from peritumoral area; NS, no significance.

  • * F score and P values were obtained by using Tukey pairwise post hoc test.

  • control > high-grade, control > low-grade P < .001; benign > low-grade, benign > high-grade P < .05; otherwise NS.

  • high-grade > control P < .05; otherwise NS.

  • § high-grade < control P < .001; high-grade > low-grade P < .05; otherwise NS.

  • | high-grade > benign, high-grade > control P < .001; low-grade > benign, low-grade > control P < .05; otherwise NS.

  • high-grade > control P = .001; high-grade > benign, low-grade > benign, low-grade > control P < .05; otherwise NS.

  • # benign > high-grade, benign > low-grade, benign > control P < .001; otherwise NS.

  • ** low-grade > high-grade, benign > high-grade, benign > control, low-grade > control P < .001; otherwise NS.

  • †† high-grade > benign, high-grade > control, low-grade > benign, low-grade > control P < .001; otherwise NS.